Salas Eduardo Rene 4
4 · ADMA BIOLOGICS, INC. · Filed Jan 2, 2025
Insider Transaction Report
Form 4
Salas Eduardo Rene
Director
Transactions
- Award
Stock Option (right to buy)
2024-12-30+20,011→ 20,011 totalExercise: $17.49Exp: 2034-12-30→ Common Stock (20,011 underlying)
Footnotes (1)
- [F1]The options were granted to the reporting person on 12/30/2024 upon joining the ADMA Biologics, Inc. Board of Directors and will vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.